对食品和药物管理局的信任:一项全国调查研究
William B Feldman1,2,3, Leah Z Rand1,3, Daniel Carpenter4
1Division of Pharmacoepidemiology and Pharmacoeconomics, Program On Regulation, Therapeutics, And Law (PORTAL), Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Clinical pharmacology and therapeutics
|May 17, 2024
概括
建立公众对美国食品和药物管理局 (FDA) 的信任至关重要. 一项调查显示,性别,地理位置,政治观点和健康满意度等因素影响FDA的不信任,突出了有针对性的宣传的必要性.
科学领域:
- 公共卫生政策 公共卫生政策
- 卫生沟通健康沟通
- 监管科学 监管科学
背景情况:
- 公众对监管机构的信任,如美国食品和药物管理局 (FDA),是政府的重要优先事项.
- 了解不信任的驱动因素对于制定有效的战略来增强公众对FDA的信任至关重要.
研究的目的:
- 调查与对美国食品和药物管理局 (FDA) 不信任相关的因素.
- 为了确定FDA信任和不信任的人口和态度相关性.
主要方法:
- 一项对2021名美国受访者的调查评估了人们对FDA的态度.
- 用四个领域的复合得分来衡量FDA信任:能力,公共利益承诺,监管遵守和专业知识.
- 采用多变量顺序逻辑回归分析来确定FDA不信任的预测因素.
主要成果:
- 美国食品和药物管理局的不信任与女性性别,农村居民,保守的政治观点,自我报告的健康状况较差和医疗保健满意度较低有显著联系.
- 关注健康和科学新闻较少的人和没有18岁以下孩子的人也报告对FDA的信任较低.
- 几率比率表明这些因素与FDA不信任之间存在不同程度的关联.
结论:
- 在多元化的美国人口中,培养对FDA的统一公众信任存在重大挑战.
- 美国食品和药物管理局应该为表现出较低信任水平的人口群体实施有针对性的外展倡议.
- 建议加强内部流程,以确保公正的决策和强大的科学诚信.
更多相关视频
09:18Feeding Experimentation Device FED: Construction and Validation of an Open-source Device for Measuring Food Intake in Rodents
Published on: February 21, 2017
8.1K
10:44Examination of Rapid Dopamine Dynamics with Fast Scan Cyclic Voltammetry During Intra-oral Tastant Administration in Awake Rats
Published on: August 12, 2015
12.7K
相关概念视频
01:25Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
01:19Pharmacovigilance
826
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
826
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
01:16Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
157
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
157
01:17Drug Nomenclature
1.7K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.7K